Intuitive Surgical, Inc. (LON:0R29)

Market Cap	130.29B -22.8%
Revenue (ttm)	7.48B +20.5%
Net Income	2.12B +23.0%
EPS	5.85 +22.6%
Shares Out	n/a
PE Ratio	61.40
Forward PE	49.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	998
Average Volume	2,099
Open	505.83
Previous Close	504.72
Day's Range	500.03 - 513.50
52-Week Range	406.50 - 608.79
Beta	1.67
RSI	30.30
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1995
• Employees: 15,638
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R29

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD